Concepedia

Wenpeng Cai

WC

Statistics

Publications

5

Citations

129

H-Index

5

Active since

2019

Affiliations

Anhui University of Science and Technology(Current)

Wenpeng Cai is an author at Anhui University of Science and Technology specializing in oncology, oncogenic signaling pathways, and medicine.

Publications per year

2019–2023

5

Publications

5

LY‑294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF‑1α pathway

Ruyue Xu, Yinci Zhang, Amin Li et al. · Molecular Medicine Reports · 2021 · 33 citations · Full text

, , +17

BEZ235 increases sorafenib inhibition of hepatocellular carcinoma cells by suppressing the PI3K/AKT/mTOR pathway.

Amin Li, Rongbo Zhang, Yinci Zhang et al. · PubMed · 2019 · 32 citations · Full text

, , +17

IGF-1R down regulates the sensitivity of hepatocellular carcinoma to sorafenib through the PI3K / akt and RAS / raf / ERK signaling pathways

Wenpeng Cai, Yongfang Ma, Song Li et al. · BMC Cancer · 2023 · 31 citations · Full text

, , +17

hGC33-Modified and Sorafenib-Loaded Nanoparticles have a Synergistic Anti-Hepatoma Effect by Inhibiting Wnt Signaling Pathway

Jing Shen, Wenpeng Cai, Yongfang Ma et al. · Nanoscale Research Letters · 2020 · 23 citations · Full text

, , +17

<scp>IL</scp>‐6 upregulates the expression of <scp>IL‐6R</scp> through the <scp>JAK2</scp>/<scp>STAT3</scp> signalling pathway to promote progression of hepatocellular carcinoma

Li Song, Ruyue Xu, Wenpeng Cai et al. · Scandinavian Journal of Immunology · 2023 · 10 citations · Full text

, , +17

1–5 of 5